XOMAP FY 2013 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$35M+4.9% YoY

Gross Profit

$8M22.8% margin

Operating Income

-$58M-164.2% margin

Net Income

-$124M-349.9% margin

EPS (Diluted)

$-10.95

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$47M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$135M

Total Liabilities

$139M

Stockholders' Equity

-$4M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$34M	+4.9%
Gross Profit	$8M	$34M	-76.0%
Operating Income	-$58M	-$57M	-2.8%
Net Income	-$124M	-$71M	-74.6%